子宮體淋巴瘤的檢視

Uterine lymphoma

淋巴瘤一般指由淋巴器官如脾臟、胸腺或淋巴結長出來的腫瘤，有時可轉移至其它部位。原發性女性生殖道淋巴瘤乃一偶然發生的淋巴結外非柯金氏淋巴瘤，而以瀰漫性大型B細胞淋巴瘤為最常見的非柯金氏淋巴瘤，約佔30-40%。女性生殖道淋巴瘤佔所有淋巴結外淋巴瘤的0.2-1.1%，其中以發生在卵巢最多，次為子宮頸和子宮體，現今尚無共識或標準的方式來診斷子宮體淋巴瘤。原發性子宮體淋巴瘤常是在手術病理標本中被發現，因為子宮體淋巴瘤很困難預做切片。子宮體淋巴瘤最適合治療之方法是化學治療，如R-CHOP（rituximab, cyclophosphamide, doxorubicin, vincristine和prednisone）。

Lymphoma arises in lymphatic organs such as the spleen, thymus, or lymph nodes and spreads to other sites. Primary lymphoma of the female genital tract is a sporadic extranodal lymphoma. Diffuse large B-cell lymphoma (DLBCL) is the most common subtype of non-Hodgkin lymphoma (NHL), representing approximately 30% to 40% of all cases. Lymphomas of the female genital tract represent 0.2% to 1.1% of all extranodal lymphomas. The sites most patients are in the ovary and cervix, followed by uterine corpus. There is no consensus or standard diagnostic protocol for uterine corpus lymphoma. Primary lymphoma of the uterine corpus is commonly discovered on final pathology of surgical staging procedures, especially for lymphoma of the uterine corpus as this is difficult locations to biopsy. The optimal treatment of uterine lymphoma seems to be chemotherapy, such as R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone).